BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4187540)

  • 21. [Study of hetero-agglutinins in viral hepatitis].
    Cargnel A; Vitali D; Medina F
    G Mal Infett Parassit; 1969 Sep; 21(9):759-64. PubMed ID: 4191376
    [No Abstract]   [Full Text] [Related]  

  • 22. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
    Maayan ML; Volpert EM; Dawry FP
    J Endocrinol Invest; 1978 Oct; 1(4):299-304. PubMed ID: 92490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization of long-acting thyroid stimulator by antibodies to euthyroid human serum.
    Adams DD; Sharard A
    Australas Ann Med; 1965 Aug; 14(3):192-4. PubMed ID: 4159565
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 25. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunological problems in thyroid diseases].
    Müller W
    Med Klin; 1969 Aug; 64(34):1487-92. PubMed ID: 4900624
    [No Abstract]   [Full Text] [Related]  

  • 27. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
    Onaya T; Kotani M; Yamada T; Ochi Y
    J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
    [No Abstract]   [Full Text] [Related]  

  • 28. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
    Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
    Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
    [No Abstract]   [Full Text] [Related]  

  • 29. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 30. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
    Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
    J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the long-acting thyroid stimulator protector with the immunoglobulin G fraction of serum from patients with thyrotoxicosis.
    Dirmikis SM; Justice SK; Munro DS
    Biochim Biophys Acta; 1975 Jan; 379(1):239-46. PubMed ID: 1115798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L.A.T.S. and Graves' disease.
    Hedley AJ; Ross IP; Crooks J
    Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
    [No Abstract]   [Full Text] [Related]  

  • 34. PRESENCE OF THE LONG-ACTING THYROID STIMULATOR IN SERUM IN MONGOLISM WITHOUT HYPERTHYROIDISM.
    MOSIER HD
    J Clin Endocrinol Metab; 1965 Aug; 25():1005-8. PubMed ID: 14328369
    [No Abstract]   [Full Text] [Related]  

  • 35. The value of IgG separation for the detection of LATS in human serum.
    Bonnyns M; Vanhaelst L
    Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
    Yagi H; Takeuchi M; Nagashima K; Suzuki S; Kuroume T; Iida Y; Konishi J; Endo K
    J Pediatr; 1983 Oct; 103(4):591-3. PubMed ID: 6137525
    [No Abstract]   [Full Text] [Related]  

  • 37. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunoelectrophoresis and simple radial immuno-diffusion tests of saliva of subjects with syphilis in the primary and secondary phases].
    Pippione M; Martina G; Sartoris S
    Minerva Dermatol; 1968 Oct; 43(10):543. PubMed ID: 4180589
    [No Abstract]   [Full Text] [Related]  

  • 39. Humoral and genetic factors in thyrotoxic Graves disease and neonatal thyrotoxicosis.
    Green WL
    JAMA; 1976 Apr; 235(14):1449-50. PubMed ID: 946443
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunofluorescent technique and long acting thyroid stimulator in human serum.
    Vanhaelst L; Bonnyns M
    Experientia; 1968 Nov; 24(11):1169-70. PubMed ID: 4889118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.